Although the data is cross-sectional, evidence suggests that antidepressant treatment alleviates the progressive increase in TSPO-VT within the duration of untreated depression, indicating a relationship between accumulated disease burden and microglia activation [157, 158]. This evidence concerns the gene TSPO and depressive symptom measurement.